Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft

John A. Gebe,Anton Preisinger,Michel D. Gooden,Leonard A. D’Amico,Robert B. Vernon

Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft

2018

John A. Gebe
Anton Preisinger
Michel D. Gooden
Leonard A. D’Amico
Robert B. Vernon

Islet transplantation remains the only alternative to daily insulin therapy for control of type 1 diabetes (T1D) in humans. To avoid the drawbacks of intrahepatic islet transplantation, we are deve...

Keywords:

Controlled release
Immunology
In vivo
Implant
Necrosis
Vascular endothelial growth factor
Islet
Cardiology
Biology
Internal medicine
Vascular endothelial growth factor A
Growth factor
Endocrinology
Transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations